163 related articles for article (PubMed ID: 37041169)
21. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
[TBL] [Abstract][Full Text] [Related]
22. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
23. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
Zhang W; Lei C; Fan J; Wang J
Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
[TBL] [Abstract][Full Text] [Related]
25. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
26. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
27. RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process.
Ke Y; Guo W; Huang S; Li Y; Guo Y; Liu X; Jin Y; Ma H
Life Sci; 2020 Jun; 250():117578. PubMed ID: 32209426
[TBL] [Abstract][Full Text] [Related]
28. A novel iron(II) phenanthroline complex exhibits anticancer activity against TFR1-overexpressing esophageal squamous cell carcinoma cells through ROS accumulation and DNA damage.
Ye J; Ma J; Liu C; Huang J; Wang L; Zhong X
Biochem Pharmacol; 2019 Aug; 166():93-107. PubMed ID: 31078603
[TBL] [Abstract][Full Text] [Related]
29. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
30. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
31. Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2001; 8(3):627-32. PubMed ID: 11295092
[TBL] [Abstract][Full Text] [Related]
32. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
33. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma.
Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533
[TBL] [Abstract][Full Text] [Related]
34. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes.
Kuo IY; Huang YL; Lin CY; Lin CH; Chang WL; Lai WW; Wang YC
J Biomed Sci; 2019 Feb; 26(1):20. PubMed ID: 30777052
[TBL] [Abstract][Full Text] [Related]
35. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
Ye L; Zhang J; Zhang Y; Gu B; Zhu H; Mao X
Biomed Res Int; 2020; 2020():9259852. PubMed ID: 32190688
[TBL] [Abstract][Full Text] [Related]
36. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
[TBL] [Abstract][Full Text] [Related]
37. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
38. Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.
Chen L; Pan J
Br J Pharmacol; 2017 Aug; 174(15):2427-2443. PubMed ID: 28444744
[TBL] [Abstract][Full Text] [Related]
39. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.
Zhao H; Yang J; Fan T; Li S; Ren X
Tumour Biol; 2012 Oct; 33(5):1363-74. PubMed ID: 22477709
[TBL] [Abstract][Full Text] [Related]
40. LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway.
Sharma U; Kaur Rana M; Singh K; Jain A
Biochem Pharmacol; 2023 Jan; 207():115372. PubMed ID: 36493845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]